Jump to content

Publications and sources: Difference between revisions

From Medico-Pharmaceutical Law Universe (by Lumen SI)
Expand source-linked scientific reference and navigation
Make the 2025 medico-pharmaceutical law book discoverable
Line 3: Line 3:


== Published works ==
== Published works ==
* [[The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration]] (2025), DOI [https://doi.org/10.53933/3qgntf55 10.53933/3qgntf55].
* [https://doi.org/10.1007/BF00764659 Biologically active substances in hydrazide derivatives of succinic heterylamides] (1989).
* [https://doi.org/10.1007/BF00764659 Biologically active substances in hydrazide derivatives of succinic heterylamides] (1989).
* [https://books.sreif.us/index.php/sreif/catalog/book/13 Vision 2035 – Medico-Pharmaceutical Law for Human Security] (2026).
* [https://books.sreif.us/index.php/sreif/catalog/book/13 Vision 2035 – Medico-Pharmaceutical Law for Human Security] (2026).

Revision as of 23:39, 11 November 2026

Publications and sources

This is a starting catalogue, not an exhaustive bibliography.

Published works

Bibliographic and project records

  • History and research foundations links early ORCID records and the selected book lineage.
  • POAMPL and public activity links preprints and institutional activities.
  • Vision 2035 Revision 2027, polished working review v0.35, 9 November 2026: a working manuscript, not automatically a published edition.

Publication platforms

Original editions, translations, revisions, preprints and final published articles should be listed separately. Individual source licences apply; this wiki does not relicense third-party works.

Expanded reading guides